Neurocrine Bioscience buy Truist Financial Co.
Start price
30.10.25
/
50%
€119.35
Target price
30.10.26
€148.09
Performance (%)
-2.22%
Price
09.01.26
€116.70
Summary
This prediction is currently active. With a performance of -2.22%, the BUY prediction by Truist_Financial_Co_ is trending in the wrong direction. This prediction currently runs until 30.10.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -2.750% | -2.750% |
| iShares Core DAX® | 3.002% | 4.755% |
| iShares Nasdaq 100 | 2.966% | 0.363% |
| iShares Nikkei 225® | 5.606% | 4.528% |
| iShares S&P 500 | 2.312% | 1.811% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its "buy" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $172.00 price target on the stock, up previously from $165.00.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€116.75
08.01.26
08.01.26
€144.77
08.01.27
08.01.27
-0.04%
09.01.26
09.01.26
